Abstract
Objective The aim of the present work was to investigate the prognostic value of serological ferritin, 100A12, procalcitonin (PCT) and APACHEII score in predicting death risk for patients with acute respiratory distress syndrome (ARDS).
Methods Forty eight ARDS patients were recruited from Feb. 2016 to Jan. 2019 from Lishui People’s Hospital. According to their prognosis (survival or death within 28 days), these 48 patients were further divided into the survival group (n=28) and death group (n=20). The serological levels of S100A12, PCT and ferritin of the 48 ARDS patients were examined within 24 hours after hospitalization. Demographic characteristics, serum S100A12, PCT and ferritin were compared between the two groups, and diagnostic analysis was performed to evaluate the clinical efficacy of these markers in predicting the death of ARDS patients.
Results The serum S100A12, ferritin and APACHEII scores of the death group were significantly higher than those of the survival group (p<0.05). However, serum PCT levels were not statistically different between the two groups (p>0.05). The death prediction sensitivity for serum S100A12, PCT, ferritin and APACHEII score were 65.0 (40.78-84.61)%, 60.00(36.05-80.88) %,75.0(50.90-91.34)% and 85.0(62.11-96.79)% respectively. The death prediction specificity for serum S100A12, PCT, ferritin and APACHEII score were 75.0(55.13-89.31)%, 60.00(36.05-80.88)%, 64.29(44.07-81.36)% and 82.14(63.11-93.94)%, respectively. The area under the ROC curve (AUC) for serum S100A12, PCT, ferritin and APACHEII score were 0.68(0.51-0.84), 0.63(0.46-0.79), 0.71(0.56-0.86) and 0.91(0.83-0.99) respectively.
Conclusion Serological ferritin, 100A12, PCT and APACHEII scores can be used as biomarkers to predict the death risk of ARDS patients.
References
1. Keddissi JI, Youness HA, Jones KR, Kinasewitz GT. Fluid management in Acute Respiratory Distress Syndrome: A narrative review. Can J Respir Ther 2019;55:1-8.10.29390/cjrt-2018-016Search in Google Scholar PubMed PubMed Central
2. Papazian L, Aubron C, Brochard L, Chiche JD, Combes A, Dreyfuss D, et al. Formal guidelines: management of acute respiratory distress syndrome. Ann Intensive Care 2019;9:69.10.1186/s13613-019-0540-9Search in Google Scholar PubMed PubMed Central
3. Luo J, Chen J, Li Q, Feng Z. Differences in Clinical Characteristics and Therapy of Neonatal Acute Respiratory Distress Syndrome (ARDS) and Respiratory Distress Syndrome (RDS): A Retrospective Analysis of 925 Cases. Med Sci Monit 2019;25:4992-4998.10.12659/MSM.915213Search in Google Scholar PubMed PubMed Central
4. Zhe Z, Xiaoyang H, Haoyuan R, Change L, Zhichun F. Extracorporeal membrane oxygenation: an efficient approach to treat acute respiratory distress syndrome after inhalation of zinc chloride from smoke bomb: a case report. Int J Clin Exp Med 2019;12(2):2042-2047.Search in Google Scholar
5. Homsi S, Milojkovic N, Homsi Y. Clinical pathological characteristics and management of acute respiratory distress syndrome resulting from influenza A (H1N1) virus. South Med J 2010;103:786-90; quiz 791-2.10.1097/SMJ.0b013e3181e6ca0cSearch in Google Scholar PubMed
6. Peñuelas O, Aramburu JA, Frutos-Vivar F, Esteban A. Pathology of acute lung injury and acute respiratory distress syndrome: a clinical-pathological correlation. Clin Chest Med 2006;27:571-8; abstract vii-viii.10.1016/j.ccm.2006.07.003Search in Google Scholar PubMed
7. Wang CY, Shang M, Zhou CL, Feng LZ, Zhou QS, Hu K. Mechanism of Cxc Chemokine Ligand 5 (CXCL5)/Cxc Chemokine Receptor 2 (CXCR2) Bio-Axis in Mice with Acute Respiratory Distress Syndrome. Med Sci Monit 2019;25:5299-5305.10.12659/MSM.915835Search in Google Scholar PubMed PubMed Central
8. Villar J, Blanco J, Kacmarek RM. Current incidence and outcome of the acute respiratory distress syndrome. Curr Opin Crit Care 2016;22:1-6.10.1097/MCC.0000000000000266Search in Google Scholar PubMed
9. Eworuke E, Major JM, Gilbert MLI. National incidence rates for Acute Respiratory Distress Syndrome (ARDS) and ARDS cause-specific factors in the United States (2006-2014). J Crit Care 2018;47:192-197..10.1016/j.jcrc.2018.07.002Search in Google Scholar PubMed
10. Chen H, Cheng ZB, Yu RG. Procalcitonin as a predictor of moderate to severe acute respiratory distress syndrome after cardiac surgery with cardiopulmonary bypass: a study protocol for a prospective cohort study. BMJ Open 2014;4:e006344.10.1136/bmjopen-2014-006344Search in Google Scholar PubMed PubMed Central
11. Brunkhorst FM, Eberhard OK, Brunkhorst R. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 1999;27:2172-6.10.1097/00003246-199910000-00016Search in Google Scholar PubMed
12. Wittkowski H, Sturrock A, van Zoelen MA, Viemann D, van der Poll T, Hoidal JR, et al. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med 2007;35:1369-75.10.1097/01.CCM.0000262386.32287.29Search in Google Scholar
13. Shekar K, Schmidt M. Integrating Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Severe Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2019;200:265-266.10.1164/rccm.201903-0594LESearch in Google Scholar
14. Del SL, Hubmayr R, Slutsky AS. Mechanical Ventilation in Acute Respiratory Distress Syndrome: Time Heals All Wounds, or Does It. Anesthesiology 2019;130:680-682.10.1097/ALN.0000000000002671Search in Google Scholar
15. Li L, Dong L, Zhao D, Gao F, Yan J. Classical dendritic cells regulate acute lung inflammation and injury in mice with lipopolysaccharide-induced acute respiratory distress syndrome. Int J Mol Med 2019;44:617-629.10.3892/ijmm.2019.4208Search in Google Scholar
16. Zinter MS, Orwoll BE, Spicer AC, Alkhouli MF, Calfee CS, Matthay MA, et al. Incorporating Inflammation into Mortality Risk in Pediatric Acute Respiratory Distress Syndrome. Crit Care Med 2017;45:858-866.10.1097/CCM.0000000000002370Search in Google Scholar
17. Puneet P, Moochhala S, Bhatia M. Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2005;288:L3-15.10.1152/ajplung.00405.2003Search in Google Scholar
18. Keane MP, Donnelly SC, Belperio JA, Goodman RB, Dy M, Burdick MD, et al. Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute respiratory distress syndrome. J Immunol 2002;169:6515-21.10.4049/jimmunol.169.11.6515Search in Google Scholar
19. Rebetz J, Semple JW, Kapur R. The Pathogenic Involvement of Neutrophils in Acute Respiratory Distress Syndrome and Transfusion-Related Acute Lung Injury. Transfus Med Hemother 2018;45:290-298.10.1159/000492950Search in Google Scholar
20. Juss JK, House D, Amour A, Begg M, Herre J, Storisteanu DM, et al. Acute Respiratory Distress Syndrome Neutrophils Have a Distinct Phenotype and Are Resistant to Phosphoinositide 3-Kinase Inhibition. Am J Respir Crit Care Med 2016;194:961-973.10.1164/rccm.201509-1818OCSearch in Google Scholar
21. Juss J, Herre J, Begg M, Bradley G, Lennon M, Amour A, et al. Genome-wide transcription profiling in neutrophils in acute respiratory distress syndrome. Lancet 2015;385 Suppl 1:S55.10.1016/S0140-6736(15)60370-1Search in Google Scholar
22. Uzunhan Y, Guglielminotti J, Maury E, Berenbaum F, Offenstadt G. Blood ferritin and isoferritins measurements may be helpful in acute respiratory distress syndrome patients. Intensive Care Med 2002;28:998.10.1007/s00134-002-1310-xSearch in Google Scholar PubMed PubMed Central
23. Sharkey RA, Donnelly SC, Connelly KG, Robertson CE, Haslett C, et al. Initial serum ferritin levels in patients with multiple trauma and the subsequent development of acute respiratory distress syndrome. Am J Respir Crit Care Med 1999;159:1506-9.10.1164/ajrccm.159.5.9809027Search in Google Scholar PubMed
24. Connelly KG, Moss M, Parsons PE, Moore EE, Moore FA, Giclas PC, et al. Serum ferritin as a predictor of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1997;155:21-5.10.1164/ajrccm.155.1.9001283Search in Google Scholar PubMed
© 2019 Xubin Chen et al., published by De Gruyter
This work is licensed under the Creative Commons Attribution 4.0 Public License.
